Soligenix
SNGX
#10223
Rank
S$21.05 M
Marketcap
S$2.09
Share price
-1.23%
Change (1 day)
-51.27%
Change (1 year)

Soligenix (SNGX) - Total debt

Total debt on the balance sheet as of September 2025 : S$0.49 Million

According to Soligenix's latest financial reports the company's total debt is S$0.49 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Soligenix - Total debt on balance sheet (from 1998 to 2025)

Total debt by year

Year Total debt Change
2024-12-31S$2.01 M-56.27%
2023-12-31S$4.61 M-66.38%
2022-12-31S$13.72 M1.93%
2021-12-31S$13.46 M-3.1%
2020-12-31S$13.89 M8003.4%
2019-12-31S$0.17 M
2018-12-31N/A
2016-12-31N/A-100%
2015-12-31S$0.41 M-91.73%
2014-12-31S$5 M-52.28%
2013-12-31S$10.49 M
2004-12-31S$0.18 M-68.99%
2003-12-31S$0.61 M-51.84%
2002-12-31S$1.26 M215.53%
2001-12-31S$0.4 M-28.28%
2000-12-31S$0.55 M-14.29%
1999-12-31S$0.65 M-1.11%
1998-12-31S$0.66 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Cleveland BioLabs
CBLI
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$0.85 B 172,109.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$33.09 B 6,630,476.49%๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
S$78.88 B 15,802,358.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$59.37 B 11,893,037.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
S$24.08 M 4,724.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$22.13 B 4,433,823.55%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel